Why the study?
The necessity of bridging EVT with IVT in AIS has been questioned, though recent studies suggest IVT is safe in patients on DOAC.
Does bridging therapy with intravenous thrombolysis improve 3-month functional independency in acute ischemic stroke patients on DOACs undergoing endovascular thrombectomy?
Comparison
Bridging therapy (IVT with EVT) vs EVT alone
Design
Registry-based propensity score matched study
Follow-up
3 months
Key result
Bridging therapy with intravenous thrombolysis prior to endovascular thrombectomy resulted in similar 3-month functional independence compared to EVT alone (36% vs. 35%) in AIS patients on DOACs.
Authors
Loading...
IVT bridging appears safe without outcome benefit in DOAC patients undergoing EVT; leaves open net value pending RCTs.
Observational (n=1,991)
Yes
Does bridging therapy with intravenous thrombolysis improve 3-month functional independency in acute ischemic stroke patients on DOACs undergoing endovascular thrombectomy?
Absolute Event Rate: 36% vs 35%
In acute ischemic stroke patients on DOACs, bridging intravenous thrombolysis before endovascular thrombectomy appears safe and yields similar functional outcomes compared to EVT alone.
Matusevicius et al. (2026) conducted an observational in Acute ischemic stroke (n=1,991). Intravenous thrombolysis (bridging therapy) vs. Endovascular thrombectomy alone was evaluated on 3-month functional independency (modified Rankin scale 0-2). Bridging therapy with intravenous thrombolysis prior to endovascular thrombectomy resulted in similar 3-month functional independence compared to EVT alone (36% vs. 35%) in AIS patients on DOACs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: